KOD

Kodiak Sciences Inc.

There isn't enough reported data to score KOD yet.

KOD Fundamentals

MetricStatus
Unavailable
Under pressure
Unavailable
Unavailable

KOD's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.

KOD PE Valuation

KOD has no meaningful PE right now: it lost money over the past year.

KOD Forward outlook

There aren't enough analyst estimates for KOD to show an outlook.

KOD Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $108.25 on Nov 12.

There is not enough scenario data to assess KOD's risk to reward.

KOD Earnings Per Share

Q4 2023: $-4.97Q1 2024: $-4.44Q2 2024: $-3.77Q3 2024: $-3.66Q4 2024: $-3.35Q1 2025: $-3.62Q2 2025: $-3.79Q3 2025: $-4.11Q4 2025: $-4.32Q1 2026: $-4.17Q2 2026: $-4.19Q3 2026: $-4.08
Q4 2023: $-4.97Q1 2024: $-4.44Q2 2024: $-3.77Q3 2024: $-3.66Q4 2024: $-3.35Q1 2025: $-3.62Q2 2025: $-3.79Q3 2025: $-4.11Q4 2025: $-4.32Q1 2026: $-4.17Q2 2026: $-4.19Q3 2026: $-4.08
QuarterTTM EPSYoY
Q3 2026-$4.08+$0.03
Q2 2026-$4.19-$0.40
Q1 2026-$4.17-$0.55
Q4 2025-$4.32-$0.97
Q3 2025-$4.11-$0.45
Q2 2025-$3.79-$0.02
Q1 2025-$3.62+$0.82
Q4 2024-$3.35+$1.62

KOD is still losing money, but less than at its worst: $4.08 per share over the past year, against $6.39 at its worst in late 2022.

KOD Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

KOD Free Cash Flow

Q4 2023: −$60MQ1 2024: −$40MQ2 2024: −$27MQ3 2024: −$21MQ4 2024: −$30MQ1 2025: −$29MQ2 2025: −$35MQ3 2025: −$33MQ4 2025: −$39MQ1 2026: −$41MQ2 2026: −$47MQ3 2026: −$46M
Q4 2023: −$60MQ1 2024: −$40MQ2 2024: −$27MQ3 2024: −$21MQ4 2024: −$30MQ1 2025: −$29MQ2 2025: −$35MQ3 2025: −$33MQ4 2025: −$39MQ1 2026: −$41MQ2 2026: −$47MQ3 2026: −$46M
QuarterFree cash flowYoY
Q3 2026-$45.8M-$12.9M
Q2 2026-$46.6M-$11.8M
Q1 2026-$41M-$11.6M
Q4 2025-$39.4M-$9.2M
Q3 2025-$32.9M-$11.6M
Q2 2025-$34.8M-$8.3M
Q1 2025-$29.3M+$10.3M
Q4 2024-$30.2M+$29.5M

KOD has burned cash in almost every quarter: −$173M over the past year, against −$127M the year before.

KOD Total Shares

Q4 2023: 52MQ1 2024: 53MQ2 2024: 53MQ3 2024: 53MQ4 2024: 53MQ1 2025: 53MQ2 2025: 53MQ3 2025: 53MQ4 2025: 53MQ1 2026: 62MQ2 2026: 63MQ3 2026: 63M
Q4 2023: 52MQ1 2024: 53MQ2 2024: 53MQ3 2024: 53MQ4 2024: 53MQ1 2025: 53MQ2 2025: 53MQ3 2025: 53MQ4 2025: 53MQ1 2026: 62MQ2 2026: 63MQ3 2026: 63M
PeriodChange %Net change
Quarterly+0.5%+332K shares
1 year+19%+10.1M shares
3 years+20%+10.5M shares
5 years-76%-196M shares
Available history-67%-126M shares

KOD has 63M diluted shares, up 19% from a year ago.

KOD Net Leverage

KOD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

KOD Weekly Momentum

MetricValueStatus
RSI78.3Overbought
Stochastic94.1Overbought

KOD's weekly RSI is 78 (overbought) and its Stochastic is 94 (overbought).

KOD PE vs Healthcare Sector

KOD has no meaningful PE right now: it lost money over the past year.

KOD Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$88.423% above
20 week MA$58.884% above
50 week MA$42.4155% above
100 week MA$25.3328% above
200 week MA$14.8632% above

KOD is in an uptrend: it's above all five of its weekly moving averages, and 632% above its 200-week average.

KOD Yearly ROI

YearStart priceEnd priceROI
2020$14.7$30.8+110%
2021$30.8$19.0-38%
2022$19.0$7.03-63%
2023$7.03$3.04-57%
2024$3.04$9.98+228%
2025$9.98$29.9+199%
2026 YTD$29.9$108.3+262%

KOD's yearly returns have swung widely, from +228% in 2024 to −63% in 2022. It's up 262% so far in 2026.

Give your agent the market.

Get API key